```

[Federal Register Volume 89, Number 28 (Friday, February 9, 2024)]
[Notices]
[Pages 9163-9164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02636]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Meeting of the National Vaccine Advisory Committee

AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) hereby gives notice that 
the National Vaccine Advisory Committee (NVAC) will hold an in-person 
meeting. The meeting will be open to the public and public comment will 
be heard during the meeting.

DATES: The meeting will be held February 22-23, 2024. The confirmed 
meeting times and agenda will be posted on the NVAC website at http://www.hhs.gov/nvpo/nvac/meetings/index.html as soon as they become 
available.

ADDRESSES: Instructions regarding attending this meeting will be posted 
online at: http://www.hhs.gov/nvpo/nvac/meetings/index.html at least 
one week prior to the meeting. Pre-registration is required for those 
who wish to attend the meeting in person or participate in public 
comment. Please register at http://www.hhs.gov/nvpo/nvac/meetings/index.html.

FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal 
Officer, Office of Infectious Disease and HIV/AIDS Policy, U.S. 
Department of Health and Human Services, Tower Building, Room, 1101 
Wootton Parkway, Rockville, MD 20852. Email: [email protected]. Phone: 202-
795-7697.

SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public 
Health

[[Page 9164]]

Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was mandated to 
establish the National Vaccine Program to achieve optimal prevention of 
human infectious diseases through immunization and to achieve optimal 
prevention against adverse reactions to vaccines. The NVAC was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program on matters related to the Program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    During this meeting, NVAC will hear presentations to support the 
recent charge on innovation from Admiral Rachel L. Levine, MD, the 
Assistant Secretary for Health and Director of the National Vaccine 
Program. NVAC will also hear presentations on recent surges in measles 
cases, the Vaccines for Children's Program, real uses of artificial 
intelligence to support vaccination efforts, and supply chains. 
Presenters will also cover ways to improve immunization of children, 
adults, and pregnant people. Please note that agenda items are subject 
to change, as priorities dictate. Information on the final meeting 
agenda will be posted prior to the meeting on the NVAC website: http://www.hhs.gov/nvpo/nvac/index.html.
    Members of the public will have the opportunity to provide comment 
at the NVAC meeting during the public comment period designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Members of the public may also submit written 
comments. Written comments should not exceed three pages in length. 
Individuals planning to submit comments should email their written 
comments or their request to provide a comment during the meeting to 
[email protected] at least five business days prior to the meeting.

    Dated: January 11, 2024.
Ann Aikin,
Acting Designated Federal Official, Office of the Assistant Secretary 
for Health.
[FR Doc. 2024-02636 Filed 2-8-24; 8:45 am]
BILLING CODE 4150-44-P
```